5-aza-2'-deoxycytidine-5'-triphosphate has been researched along with HIV Coinfection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bonnac, L; Clouser, CL; Daly, MB; Kim, B; Landman, SR; Mansky, LM; Patterson, SE; Rawson, JM; Reilly, CS; Roth, ME; Xie, J | 1 |
Daly, MB; Greggs, WM; Kim, B; Mansky, LM; McDaniel, YZ; Patterson, SE; Roth, M; Talledge, N | 1 |
2 other study(ies) available for 5-aza-2'-deoxycytidine-5'-triphosphate and HIV Coinfection
Article | Year |
---|---|
Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase.
Topics: Anti-HIV Agents; Azacitidine; Dose-Response Relationship, Drug; Enzyme Inhibitors; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Ribonucleotide Reductases; Structure-Activity Relationship | 2016 |
Distinct Antiretroviral Mechanisms Elicited by a Viral Mutagen.
Topics: Animals; Antiviral Agents; Azacitidine; Cats; Cytidine Triphosphate; HIV; HIV Infections; Humans; Leukemia Virus, Feline; Leukemia Virus, Murine; Leukemia, Experimental; Mice; Mutagenesis; Mutagens; Mutation; Retroviridae Infections; Tumor Virus Infections; Virus Replication | 2021 |